Home » Topics » BioWorld Science

BioWorld Science
RSS

SYT7 identifies gastric cancer with hepatic metastasis

Feb. 5, 2018

Takeda describes novel Toll-like receptor 4 antagonists

Feb. 5, 2018

Celgene begins tender offer for Juno Therapeutics

Feb. 5, 2018

EMA accepts fremanezumab MAA

Feb. 5, 2018

Pfizer reflects on milestones of fourth quarter 2017

Feb. 5, 2018

Five-year D-CARE trial of denosumab in breast cancer misses primary endpoint

Feb. 2, 2018

Veliparib combined with oxaliplatin and capecitabine proven safe in solid cancers

Feb. 2, 2018

Affimed reveals new data from clinical studies of AFM-13

Feb. 2, 2018

Japanese submission seeks approval of Ventana OptiView ALK as companion diagnostic for Alecensa

Feb. 2, 2018

Roche presents new compounds for HBV

Feb. 2, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...